Careful consideration when responding to new data: dolutegravir and pregnancy
This case highlights the current complexities of managing women in the early stages of pregnancy presenting on dolutegravir-based regimens. When responding to new data, there is an important decision to be made, between the potential, uncertain risk of teratogenicity against the potential increased...
Saved in:
Main Authors: | C. Foster (Author), S. Fidler (Author), E.G.H. Lyall (Author), G.P.T. Taylor (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HIV-1 resistance to dolutegravir: update and new insights
by: Mark A. Wainberg, et al.
Published: (2015) -
Dolutegravir for second-line treatment: Programmatic implications of new evidence
by: Ying Zhao, et al.
Published: (2022) -
Knowledge and perceptions about Dolutegravir and Dolutegravir counselling: a qualitative study among women living with HIV
by: John C. Chapola, et al.
Published: (2023) -
Long-acting dolutegravir formulations prevent neurodevelopmental impairments in a mouse model
by: Emma G. Foster, et al.
Published: (2023) -
Lesão hepática induzida por dolutegravir
by: Fernando Carmo Novais Júnior, et al.
Published: (2023)